Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Papamichail

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|August 16, 2008
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapyConstantin N Baxevanis, Sonia A Perez, Michael Papamichail
Critical Reviews in Clinical Laboratory Sciences|August 5, 2009
Cancer immunotherapyConstantin N Baxevanis, Sonia A Perez, Michael Papamichail
Oncoimmunology|June 22, 2012
New insights into the role of NK cells in cancer immunotherapyMaria Salagianni, Constantin N Baxevanis, Michael Papamichail, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Invariant chain-peptide fusion vaccine using HER-2/neuSonia A Perez, George E Peoples, Michael Papamichail, et al.
Cancer Immunology, Immunotherapy : CII|May 28, 2004
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumorsAngelos D Gritzapis, Nectaria N Sotiriadou, Michael Papamichail, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2007
Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cellsDemosthenes G Katritsis, Panagiota Sotiropoulou, Eleftherios Giazitzoglou, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2014
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and predictionSonia A Perez, Eleftheria A Anastasopoulou, Michael Papamichail, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2003
Natural killer lymphocytes: biology, development, and functionMichael Papamichail, Sonia A Perez, Angelos D Gritzapis, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2003
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapyConstantin N Baxevanis, Panagiota A Sotiropoulou, Nectaria N Sotiriadou, et al.
Cancer Research|March 18, 2010
Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cellsAngelos D Gritzapis, Ioannis F Voutsas, Eftychia Lekka, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|August 16, 2008
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapyConstantin N Baxevanis, Sonia A Perez, Michael Papamichail
Critical Reviews in Clinical Laboratory Sciences|August 5, 2009
Cancer immunotherapyConstantin N Baxevanis, Sonia A Perez, Michael Papamichail
Oncoimmunology|June 22, 2012
New insights into the role of NK cells in cancer immunotherapyMaria Salagianni, Constantin N Baxevanis, Michael Papamichail, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Invariant chain-peptide fusion vaccine using HER-2/neuSonia A Perez, George E Peoples, Michael Papamichail, et al.
Cancer Immunology, Immunotherapy : CII|May 28, 2004
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumorsAngelos D Gritzapis, Nectaria N Sotiriadou, Michael Papamichail, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2007
Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cellsDemosthenes G Katritsis, Panagiota Sotiropoulou, Eleftherios Giazitzoglou, et al.
Cancer Immunology, Immunotherapy : CII|July 24, 2014
AE37 peptide vaccination in prostate cancer: identification of biomarkers in the context of prognosis and predictionSonia A Perez, Eleftheria A Anastasopoulou, Michael Papamichail, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2003
Natural killer lymphocytes: biology, development, and functionMichael Papamichail, Sonia A Perez, Angelos D Gritzapis, et al.
Cancer Immunology, Immunotherapy : CII|December 20, 2003
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapyConstantin N Baxevanis, Panagiota A Sotiropoulou, Nectaria N Sotiriadou, et al.
Cancer Research|March 18, 2010
Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cellsAngelos D Gritzapis, Ioannis F Voutsas, Eftychia Lekka, et al.
Pageof 7